Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a effective class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, promoting insulin secretion and reducing glucagon release. Recent research have yielded a di

In the realm of peptide synthesis, achieving high yield and purity is paramount. A multitude of factors impact manufacturing processes, and optimizing these variables is crucial for success. Robust purification techniques, coupled with meticulous synthesis conditions, are key to minimizing impuri